Latest Feature

Podcast: Haemonetics CEO Brian Concannon at MassDevice.com's DeviceTalks

Haemonetics CEO Brian Concannon discusses how the company will transform blood management in the coming years at MassDevice.com's DeviceTalks Boston event.

Calhoun Vision aims to disrupt ophthalmology with its light-adjustable lens

Calhoun Vision CEO Verne Sharma tells MassDevice.com why his company's light-adjustable lens will disrupt the practice of ophthalmology.

Silicon Valley in-depth: Unraveling arrhythmia with iRhythm CEO Kevin King

Kevin King, CEO of Silicon Valley digital health company iRhythm, tells MassDevice about the promise of Big Data and how remote patient monitoring can reveal intricate details of the habits of the heart.

Podcast: Covidien's Enxing Seng talks Medtronic merger, future of medicine at De

Covidien's Stacy Enxing Seng speaks to MassDevice.com about the Medtronic merger during our DeviceTalks Minnesota event.

FDA cybersecurity rejections are on the way

The FDA is ramping up its cybersecurity labs and may start rejecting insecure technologies sooner than you think.

Subscribe to the MassDevice
Newsletter
Enter your email:

Need Medtech news in a minute? We Deliver!


MassDevice +3,+5 and +7 newsletters get you caught up on all the mission critical news you need in med tech. Sign up today for our free newsletter.

Medtronic settles insulin pump beef for $2.8M

July 25, 2014 by Arezu Sarvestani

Medtronic agrees to pay $2.8 million to close the books on a multi-state and federal lawsuit accusing the company of illegally soliciting insulin pump patients to replace their devices.

Medtronic settles insulin pump beef for $2.8M

Federal and state regulators agreed to a $2.8 million settlement with medtech titan Medtronic (NYSE:MDT) to close the books on a years-old concern over insulin infusion pumps.

Layoffs: St. Jude cuts 274 in California

July 25, 2014 by Arezu Sarvestani

St. Jude Medical informs California state regulators that it's planning to lay off 274 from a facility in Sylmar.

Layoffs: St. Jude cuts 274 from California plant

St. Jude Medical (NYSE:STJ) is about to hand out more than 270 pink slips to employees at a facility in Sylmar, Calif., according to a notice filed with the state's Employment Development Dept.

Bard: We're on track for early 2015 Lutonix approval

July 25, 2014 by Brad Perriello

Executives at C.R. Bard say the company is on track for an early 2015 approval for its Lutonix drug-eluting balloon for treating peripheral artery disease.

Bard: We're on track for early 2015 Lutonix approval

C.R. Bard (NYSE:BCR) is on track for an early 2015 U.S. approval of its Lutonix drug-eluting balloon, company executives said yesterday after reporting earnings growth that topped expectations.

DICOM Grid raises $6M in an inside funding round | Medtech funding for the week of July 21, 2014

July 25, 2014 by MassDevice

Here's a look at some of the top funding stories for medical device companies this week: DICOM Grid raises $6M for cloud-based medical imaging systems; Welch Allyn leads $7M round for Cardiac Insight; Biolase launches $12M private placement amid internal turmoil, shares soar; Trice Medical reels in $12M, ex-Embrella founder O'Donnell

DICOM Grid raises $6M for cloud-based medical imaging systems

July 18, 2014 by Arezu Sarvestani

DICOM Grids raises $6M for cloud-based imaging management

Press Release: Sorin Group announces CE Mark approval for Crown PRT heart valve

July 25, 2014 by MassDevice

New stented aortic bioprosthesis delivers outstanding implantability and performance.

Press Release: Sorin Group announces CE Mark approval for Crown PRT heart valve

Milan, Italy – Sorin Group, (Reuters Code: SORN.MI), a global medical device company and a leader in the treatment of cardiovascular diseases, announced today it has been granted CE mark certification for its innovative stented aortic bioprosthesis Crown PRT, now commercially available in Europe.

Sorin touts E.U. approval for next-gen heart valve

July 25, 2014 by Arezu Sarvestani

Italian device maker Sorin Group lands European regulatory approval for its next-generation Crown PRT replacement aortic heart valve.

Sorin touts E.U. approval for next-gen heart valve

Sorin Group (BIT:SRN) announced this week that it landed European CE Mark approval for its latest aortic heart valve, the Crown PRT.

Ocular Therapeutix prices IPO below range

July 25, 2014 by Brad Perriello

Ocular Therapeutix prices its initial public offering at $13 per share, a dollar below its prior range of $14 to $16.

Ocular Therapeutix prices IPO below range

Ocular Therapeutix said this morning that it plans to put up 5 million shares at $13 apiece on the NASDAQ exchange today.

That's a dollar below the projected price range the Bedford, Mass.-based company issued earlier this month.

Covidien's Q3 sales meet The Street, earnings top estimates

July 25, 2014 by Brad Perriello

Covidien's fiscal 3rd-quarter sales come in dead even with expectations on Wall Street as its earnings top analysts' consensus estimate.

Covidien's Q3 sales meet The Street, earnings top estimates
Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp